0001193125-25-274194
SEC filingProFrac reported a 30% revenue decline to $403.1M in Q3 2025, swinging to an operating loss of $78.8M, driven by reduced customer activity amid low commodity prices, while liquidity was bolstered by a $79M equity raise.
ProFrac's Q3 2025 revenue fell 30% year-over-year to $403.1 million, driven by a 32% decline in Stimulation Services revenue ($342.9M vs $507.1M) due to lower average active fleets and pricing. The company reported an operating loss of $78.8 million compared to a $4.3 million loss in Q3 2024, reflecting the revenue drop and elevated other operating expenses ($11.8M vs $15.5M). Net loss attributable to ProFrac widened to $100.9 million from $45.2 million, with EPS of -$0.60 versus -$0.29.
For the first nine months, revenue declined 13% to $1,505.3 million from $1,736.2 million, with operating loss of $120.8 million vs $13.6 million. Net loss attributable to ProFrac was $226.4 million (EPS -$1.41) versus $110.1 million (EPS -$0.71) in the prior year. The prior year included a $74.5 million goodwill impairment charge.
Total assets decreased to $2,742.4 million from $2,988.1 million at year-end 2024, driven by lower property, plant and equipment ($1,567.9M vs $1,761.2M) and reduced receivables. Cash increased to $58.0 million from $14.8 million due to $140.0 million in operating cash flow, $79.0 million equity issuance, and $31.2 million from financing. Total debt principal fell to $1,094.0 million from $1,138.9 million, mainly from net repayments of $65.2 million on term loans. Liquidity (cash plus availability under ABL) stood at $94.5 million as of September 30, 2025.
Operating cash flow for nine months was $140.0 million, down from $290.8 million in 2024, primarily from lower earnings. Capital expenditures totaled $133.3 million (vs $191.8M), resulting in free cash flow of $6.7 million. The company generated positive free cash flow despite the profit decline, aided by reduced capex. Financing activities included $82.4 million in common stock proceeds and net debt repayments. Cash and equivalents rose by $43.2 million during the period.
Management attributed the revenue decline to lower commodity prices and reduced customer activity beginning in April 2025. Cost reduction initiatives include headcount cuts, SG&A reductions, and operational efficiency improvements. The company expects Q4 2025 revenue to improve sequentially. Key liquidity actions taken: $79 million equity raise in August 2025, sale of an intercompany note receivable for $40 million in November 2025, and commitments for $40 million additional senior notes in December 2025 (subject to closing). They also target up to $40 million in incremental debt and non-collateralized asset sales. Full-year 2025 capex is expected at $160-$190 million. Alpine's debt covenant testing was deferred to March 2027.
Segment performance: Proppant Production segment was a bright spot with 45% revenue growth due to higher pricing and a mix shift from mine-gate to wellsite pricing (intercompany sales mix). Manufacturing revenue fell 22% on lower intercompany demand. Other segment (includes Flotek and Livewire) grew 19%. Adjusted EBITDA (segment measure) was $40.9 million for Q3 vs $134.8 million a year ago. The company recorded a $12.8 million provision for credit losses related to an insolvent customer, $8.3 million in transaction costs, and $9.3 million in litigation expenses. It also recognized $7.6 million in non-cash revenue from amortization of acquired unfavorable contracts (down from $39.1M in 2024). An immaterial error correction was made in Q3 2025 regarding Flotek's capitalized costs, reducing property, plant and equipment and increasing other operating expenses by $3.7 million. Goodwill remained stable at $301.3 million with no impairment in 2025.